If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

AGM Statement and Trading Update

25 Nov 2025 07:00

RNS Number : 8147I
Transense Technologies PLC
25 November 2025
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

25 November 2025

 

Transense Technologies plc

("Transense", the "Company" or the "Group")

 

AGM Statement and Trading Update

 

Transense Technologies plc ("Transense", the "Company" or the "Group"), a leading provider of specialist sensing solutions and measurement systems, today issues a trading update for the period since 1 July 2025 ahead of its Annual General Meeting at 12 noon.

 

Financial Performance

 

The Group's performance in the current financial year to date has been characterised by a strong performance at SAWsense, with revenues more than doubling compared to the prior year, and revenues at Translogik broadly in line with last year. The composite rate of growth in revenue excluding Bridgestone iTrack royalty was approximately 20% compared with the same four month period last year.

 

Overall, Group revenues for the period reflect the reduction in Bridgestone iTrack royalty income following the contractual 40% unit rate adjustment. To date, this reduction has been partially offset by increased installation volumes and a favourable US dollar exchange rate.

 

Gross margins are strong at over 85% of revenue. The Group remains profitable and is cash generative, supported by disciplined cost management.

 

Strategic and Commercial Progress

 

Transense is increasingly focused on high-value, high-growth sectors where its proprietary sensing technologies deliver unique advantages.

 

SAWsense adoption in aerospace and motorsport production applications continues to accelerate, and the pipeline of new projects in robotics and automotive electric propulsion systems is particularly strong. These areas represent significant long-term opportunities as global industries transition toward electrification, automation, and advanced performance control.

 

Collaborative development programs, supported by UK Government grant funding, are progressing well and are expected to partially underpin future revenue streams. The Company's technology is being integrated into next-generation platforms, positioning Transense as a critical enabler of innovation in these markets.

 

Translogik is also advancing its strategic roadmap, with new product launches such as the Smart Tyre Inflator (TLGi) in November and further enhancements planned for the second half of the year. While revenues from existing tyre major customers have yet to return to historic levels, new business conversion is accelerating, including agreements with another global tyre manufacturer and trials with fleet operators and service centres. These initiatives are expected to drive sustainable growth in the medium term.

 

Outlook

 

Current-year market expectations are predicated on revenue growth (excluding iTrack royalty) in excess of 50%. The Board considers that meeting this expectation in the full year remains achievable, and is confident that the Company's strong positioning in robotics, electric drives, and aerospace will deliver long-term growth and shareholder value. With a robust technology portfolio, expanding customer base, and healthy cash position, Transense continues to be well placed to capitalise on structural trends in electrification and automation.

 

 

Online access to the AGM

Shareholders that wish to attend the online AGM should register for the event in advance by using the following link: https://www.investormeetcompany.com/transense-technologies-plc/register

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

 investor.relations@transense.co.uk

 

Notes to Editors:

 

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Airbus, Motion Applied (formerly McLaren Applied), and several other confidential OEM's and Tier One automotive, aerospace and industrial machinery suppliers.

 

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030. 

 

 

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIBMTMTJTTIA
Date   Source Headline
4th Dec 202411:43 amRNSHolding(s) in Company
28th Nov 202411:24 amRNSHolding(s) in Company
27th Nov 20245:18 pmRNSResult of AGM
27th Nov 20247:00 amRNSAGM Statement and Trading Update
20th Nov 20243:22 pmRNSHolding(s) in Company
30th Oct 20245:27 pmRNSDirector/PDMR Shareholding - acquisition of shares
21st Oct 20247:00 amRNSPosting of Annual Report & Notice of AGM
10th Oct 202411:05 amRNSDirector/PDMR Shareholding - acquisition of shares
27th Sep 202411:28 amRNSHolding(s) in Company
26th Sep 202410:42 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSFinal Results & Investor Presentation
18th Sep 20247:00 amRNSTransense Selected for £11 Million EV R&D Project
3rd Sep 20247:00 amRNSNotice of Annual Results & Investor Presentation
1st Aug 202410:35 amRNSDirector/PDMR shareholding – acquisition of shares
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSTrading Update
26th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
18th Jun 20247:00 amRNSDirector/PDMR Shareholding – acquisition of shares
30th May 20245:25 pmRNSHolding(s) in Company
30th May 20245:20 pmRNSHolding(s) in Company
24th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSUpcoming Investor & Analyst Events
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.